Internal Medicine, Hematology & Oncology · Newburgh, NY
NPI
1174639751
Since 2006
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
1
Medicare group memberships
Hospitals
4
Hospital affiliations
5109 Route 9w Ste 2
Newburgh, NY, 12550
Phone (845) 562-6240
Groups this clinician bills Medicare through
Medicare paid, 2024
$984K
96,926 services
Medicare patients, 2024
282
Average age 75
Drug cost, 2024
$2.8M
1,035 prescriptions
Company payments, 2025
$1,443
From 23 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Fauzia Paracha was code J2405 (injection, ondansetron hydrochloride, per 1 mg), 4,568 times for 21 patients. In total Fauzia Paracha billed 96,926 services in 73 codes, and Medicare paid $984K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2019-03-21.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J2405 Injection, ondansetron hydrochloride, per 1 mg | Office | 4,568 | 21 | $0.07 | $338 |
| Q5106 Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for non-esrd use), 1000 units | Office | 2,840 | 13 | $5.81 | $17K |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 1,582 | 17 | $0.09 | $143 |
| J2916 Injection, sodium ferric gluconate complex in sucrose injection, 12.5 mg | Office | 1,436 | 32 | $1.67 | $2,405 |
| 36415 Venipuncture Blood Collection | Office | 1,310 | 215 | $8.65 | $11K |
| J7050 Infusion, normal saline solution, 250 cc | Office | 973 | 56 | $0.51 | $499 |
| 96367 Intravenous Infusion, Hydration | Office | 915 | 23 | $21.96 | $20K |
| 99214 Office E&M - Established | Office | 910 | 189 | $91.41 | $83K |
| 85025 Blood Count | Office | 721 | 112 | $7.61 | $5,487 |
| 96372 Injection Administration | Office | 597 | 85 | $10.71 | $6,395 |
| 99213 Office E&M - Established | Office | 436 | 103 | $66.35 | $29K |
| J3420 Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 354 | 65 | $0.94 | $333 |
| 96365 Intravenous Infusion, Hydration | Office | 313 | 40 | $46.97 | $15K |
| 96413 Chemotherapy Administration | Office | 295 | 20 | $99.83 | $29K |
| 96415 Chemotherapy Administration | Office | 192 | 17 | $21.39 | $4,107 |
By year: 2022 $872K for 171,495 services; 2023 $730K for 212,961 services; 2024 $984K for 96,926 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 1,310 | 215 | $8.65 | $11K |
| 85025 Blood Count | 721 | 112 | $7.61 | $5,487 |
Medicare prescription drug claims, 2024
In 2024, the drug Fauzia Paracha prescribed most often to Medicare patients was Letrozole, with 108 prescriptions and refills. In total Fauzia Paracha wrote 1,035 Medicare prescriptions that cost $2.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Letrozole Generic | 108 | 241 | 27 | $1,936 |
| Eliquis Apixaban | 91 | 133 | 18 | $75K |
| Warfarin Sodium Generic | 81 | 107 | 12 | $454 |
| Xarelto Rivaroxaban | 40 | 60 | Under 11 | $34K |
| Lanreotide Acetate Generic | 29 | 29 | Under 11 | $247K |
| Anastrozole Generic | 28 | 48 | Under 11 | $475 |
| Sodium Chloride 0.9 % Sodium Chloride | 27 | 27 | Under 11 | $126 |
| Hydroxyurea Generic | 26 | 36 | Under 11 | $486 |
| Gabapentin Generic | 25 | 25 | Under 11 | $171 |
| Alprazolam Generic | 22 | 22 | Under 11 | $39.32 |
| Keytruda Pembrolizumab | 22 | 22 | Under 11 | $337K |
| Imfinzi Durvalumab | 21 | 21 | Under 11 | $256K |
| Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen | 21 | 21 | Under 11 | $310 |
| Lenalidomide Generic | 18 | 18 | Under 11 | $235K |
| Acyclovir Generic | 16 | 24 | Under 11 | $114 |
Brand drugs: 376 claims; generic drugs: 659 claims; opioid claims: 53.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Fauzia Paracha $1,443 ($1,443 in general payments such as food, travel and fees) from 23 companies. The largest payer was Janssen Biotech, Inc. with $233.
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. JNJ | 7 | $233 |
| Novartis Pharmaceuticals Corporation NVS | 7 | $190 |
| Lilly USA, LLC LLY | 3 | $149 |
| Pfizer Inc. PFE | 9 | $132 |
| Seagen Inc. PFE | 1 | $99.95 |
| Merck Sharp & Dohme LLC MRK | 4 | $96.53 |
| AstraZeneca Pharmaceuticals LP AZN | 4 | $89.2 |
| Daiichi Sankyo Inc. 4568.T | 2 | $53.87 |
| E.R. Squibb & Sons, L.L.C. BMY | 2 | $52.34 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 2 | $39.46 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.